EUVIMEDEUVIMED entdecken
Crossref

SEW2871 attenuates myocyte necroptosis in heart failure through inhibition of oxidative stress and inflammatory cytokines

Hong-Xia Guo, Run-Nan Tantai, Bin Yang, Li-Guo Yang, Yuan Ma, Hui-Ping Zhao, Jing Wang, Xiao-Juan Zhang, Rui-Hua Wang, Fei Wang, Jia-Pu Wang, Rui-Fang Chi und 3 weitere

British Journal of Pharmacology · 2025-06 · 182 (12) · 2772-2789

DOI: 10.1111/bph.70005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 10.03.2025. Verfasst von Hong-Xia Guo und 14 weiteren Autor:innen. Beteiligte Einrichtung: The Second Hospital of Shanxi Medical University, Taiyuan, China. Hauptthemen laut MEDLINE: Oxidative Stress, Necroptosis, Heart Failure, Cytokines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Natural Science Foundation of Shanxi Province, National Natural Science Foundation of China, Scientific Research Project of Shanxi Provincial Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Sphingosine‐1‐phosphate (S1P)/S1P receptor signalling exerts cardioprotective effects. However, the effect of the selective S1P 1 receptor agonist SEW2871 on myocyte necroptosis in heart failure and the underlying mechanisms are unknown. In the present study, we tested the hypothesis that SEW2871 attenuates myocyte necroptosis in heart failure through inhibition of oxidative stress and inflammatory cytokines. Experimental Approach Eight‐week‐old male C57BL/6J mice underwent myocardial infarction (MI) or sham operation. The animals were randomized to receive SEW2871 (5 mg·kg −1 ·day −1 , i.p) or placebo for 4 weeks. Key Results MI mice exhibited the increases in left ventricular (LV) end‐diastolic dimension, LV end‐systolic dimension, LV mass and lung weight and a decrease in LV ejection fraction, indicating LV dilation, LV systolic dysfunction and lung congestion, and these alterations were attenuated by the SEW2871 treatment. Myocardial expression of 8‐hydroxy‐2′‐deoxyguanosine (8‐OHdG), a marker of oxidative stress, inflammatory cytokines tumour necrosis factor‐α (TNF‐α), interleukin‐1β and interleukin‐6, and phosphorylated RIPK1 (p‐RIPK1), p‐RIPK3 and p‐MLKL, reflective of their respective kinase activities, markers of necroptosis, was markedly increased in the MI placebo group, and the increase was abolished by the SEW2871 treatment. Similarly, intracellular levels of reactive oxygen species, inflammatory cytokines, p‐RIPK1, p‐RIPK3 and p‐MLKL protein expression were increased in H9C2 cardiomyocytes under mimic ischaemia and the increases were prevented by the SEW2871 treatment. Conclusion and Implications The selective S1P 1 receptor agonist SEW2871 attenuates myocyte necroptosis through inhibition of oxidative stress and inflammatory cytokines, leading to improvement of LV remodelling and function in heart failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidative StressNecroptosisHeart FailureCytokinesMyocytes, CardiacOxadiazolesThiophenesAnimalsMaleMice, Inbred C57BLMiceMyocardial Infarction

Stichwörter der Autor:innen

SEW2871heart failureinflammatory cytokinesmyocardial infarctionnecroptosisoxidative stress

Substanzen

CytokinesSEW2871OxadiazolesThiophenes

Autor:innen und Institutionen

  • The Second Hospital of Shanxi Medical University, Taiyuan, China.
  • Shanxi Medical University, Taiyuan, China.
  • Shanxi Provincial People's Hospital, Taiyuan, China.
  • Shanxi Province Cardiovascular Hospital, Taiyuan, China.
  • Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

ORCID-Profile: Fu-Zhong Qin

Förderung

  • Natural Science Foundation of Shanxi Province
  • National Natural Science Foundation of China
  • Scientific Research Project of Shanxi Provincial Health Commission

Zitieren

APA

Guo, H. X., Tantai, R. N., Yang, B., Yang, L. G., Ma, Y., Zhao, H. P., Wang, J., Zhang, X. J., Wang, R. H., Wang, F., Wang, J. P., Chi, R. F., Qin, F. Z., Li, B., & Liu, Y. X. (2025). SEW2871 attenuates myocyte necroptosis in heart failure through inhibition of oxidative stress and inflammatory cytokines. British Journal of Pharmacology, 182(12), 2772-2789. https://doi.org/10.1111/bph.70005

Vancouver

Guo HX, Tantai RN, Yang B, Yang LG, Ma Y, Zhao HP, et al. SEW2871 attenuates myocyte necroptosis in heart failure through inhibition of oxidative stress and inflammatory cytokines. British Journal of Pharmacology. 2025;182(12):2772-2789. doi:10.1111/bph.70005

BibTeX
@article{Guo2025,
  author = {Guo, Hong-Xia and Tantai, Run-Nan and Yang, Bin and Yang, Li-Guo and Ma, Yuan and Zhao, Hui-Ping and Wang, Jing and Zhang, Xiao-Juan and Wang, Rui-Hua and Wang, Fei and Wang, Jia-Pu and Chi, Rui-Fang and Qin, Fu-Zhong and Li, Bao and Liu, Ya-Xin},
  title = {SEW2871 attenuates myocyte necroptosis in heart failure through inhibition of oxidative stress and inflammatory cytokines},
  journal = {British Journal of Pharmacology},
  year = {2025},
  volume = {182},
  number = {12},
  pages = {2772--2789},
  doi = {10.1111/bph.70005}
}
Kostenlos starten →